Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

The study identified diverse cell types and gene expressions in ovarian steroid cell tumors, improving understanding of this rare tumor.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

The drug combination was safe and showed promise in treating advanced tumors.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Sirolimus can reduce tumor cell size in TSC-related skin tumors, but continuous treatment is needed to maintain benefits.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Lymphangiosarcoma was confirmed in cats with specific skin symptoms using a lymphatic marker.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Scalp melanomas are more dangerous and likely to recur or cause death than other head and neck melanomas.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

The research shows that skin cancer likely originates from hair follicles and that certain cell populations expand to promote skin cancer growth.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.